Stay updated on CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page shows a new site revision tag, updating from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedThe site-wide operating-status notice regarding government funding has been removed from the page.SummaryDifference0.5%

- Check42 days agoChange DetectedThe screenshots show a redesigned header and revised layout on the Record History page, while the version list and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference11%

- Check78 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new version but no substantive content changes.SummaryDifference0.3%

- Check92 days agoChange DetectedThe page now displays Revision: v3.0.2, replacing v3.0.1; the Back to Top link was removed. No other core content, pricing, stock, or time-slot information appears to have changed.SummaryDifference0.6%

Stay in the know with updates to CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.